We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




System Tests Blood for Infectious Diseases

By HospiMedica staff writers
Posted on 10 Aug 2006
An infectious-disease testing system, designed specifically for high-output automation in large blood banks, has been launched in Europe and other countries outside the United States.

The Quadriga BeFree System is a fully automated, high-throughput system used to screen blood for common infectious diseases such as human immunodeficiency virus (HIV) and hepatitis. More...
The system was developed by Dade Behring (Deerfield, IL, USA), and will be used by large, mid-to high-volume blood bank laboratories to screen donated blood prior to being used for blood transfusion. This process helps to ensure that donated blood is safe for the transfusion recipient.

Features of the system, such as automated patient sample handling and verification, automated barcode identification of patient samples, and continuous monitoring of the instrument's status make the testing for infectious diseases safe and reliable.

Outside the United States, Dade Behring offers assays and analyzers using microtiter plates for infectious disease testing. Analyzers are used in both medium- to high-volume hospital laboratories. The Quadriga BeFree Systems are designed specifically for high-output automation in large blood banks.

Dade Behring is dedicated to clinical diagnostics. It offers a wide range of products, systems, and services designed to meet the day-to-day needs of laboratories. "In this industry, we have the opportunity to make a difference in the quality of life of patients while providing our laboratory customers with the innovative solutions they need,” said Jim Reid-Anderson, chairman, president, and CEO, Dade Behring. "This new product is a perfect example of meeting our customer's relevant needs and also enhancing patient care.”



Related Links:
Dade Behring

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.